Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma. [electronic resource]
Producer: 20010712Description: 213-4 p. digitalISSN:- 0361-8609
- Adrenal Gland Neoplasms
- Adult
- Alkylating Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20 -- immunology
- Combined Modality Therapy
- Drug Resistance
- Humans
- Immunization, Passive
- Immunoglobulin G -- blood
- Immunosuppressive Agents -- therapeutic use
- Immunotherapy
- Lymphoma, B-Cell -- blood
- Lymphoma, Non-Hodgkin -- blood
- Male
- Neoplasm Proteins -- blood
- Neoplasms, Multiple Primary
- Pheochromocytoma
- Purpura -- etiology
- Purpura, Thrombocytopenic, Idiopathic -- drug therapy
- Remission Induction
- Rituximab
- Splenectomy
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.